title: Polyclonal anti-thymocyte globulins influence apoptosis in reperfused tissues after ischaemia in a non-human primate model.
abstract: Reperfusion triggers the expression of inflammatory cytokines and adhesion molecules that increase the rate of apoptosis in the reperfused tissues after ischaemia, thus worsening the outcome of the grafts. Polyclonal anti-thymocyte globulins (pATGs) are able to reduce the number of lymphocytes as well as block adhesion molecules and induce apoptosis in T-lymphocytes through Fas-ligand. The aims of this study were to investigate the influence of pATGs on the prevention of apoptosis of reperfused tissues after ischaemia and to monitor their capability to enhance lymphocyte apoptosis thus decreasing the deleterious effects of ischaemia/reperfusion injury (IRI). Extremities of cynomolgus monkeys ( n=8) were flushed via either the femoral or the brachial artery. After 60 min of ischaemia the limbs were reperfused with human blood. ATG was added to the blood in a therapeutic dose 20 min prior to reperfusion of the extremities. Surgically available limbs ( n=20) were assigned to the following groups: ATG group ( n=10) and control group (without ATG; n=10). DNA fragmentation analysis was performed in situ to detect apoptosis at the single-cell level. Our study shows an increased rate of muscle and connective tissue apoptosis in the control group compared with the ATG-treated group. Cells found in the vascular areas present different rates of apoptosis, with enhanced cellular death of endothelium and connective perivascular areas being observed in the control group. The group treated with ATG shows an increased rate of white blood cell (WBC) apoptosis in vascular and perivascular areas. Previous studies have shown that pATGs are able to induce apoptosis as well as complement-mediated cell death in peripheral T-lymphocytes in vitro. Our results confirm that pATGs not only increase the rate of apoptosis of WBCs in vivo but also have a protective effect on the reperfused tissue. This may alleviate the damage after reperfusion of solid-organ transplantation.
authors.affiliation: Institute for Surgical Research, LM University, Marchioninistrasse 27, 81377 Munich, Germany. abeiras@icf.med.uni-muenchen.de
authors.forename: Andres
authors.initials: A
authors.lastname: Beiras-Fernandez
authors.forename: Eckart
authors.initials: E
authors.lastname: Thein
authors.forename: Daniel
authors.initials: D
authors.lastname: Chappel
authors.forename: Rosalía
authors.initials: R
authors.lastname: Gallego
authors.forename: Dolores
authors.initials: D
authors.lastname: Fernandez-Roel
authors.forename: Gregor
authors.initials: G
authors.lastname: Kemming
authors.forename: Claus
authors.initials: C
authors.lastname: Hammer
mesh_terms: D000818:Animals; D000961:Antilymphocyte Serum / Q000494:pharmacology*; D017209:Apoptosis / Q000187:drug effects / Q000276:immunology*; D003238:Connective Tissue / Q000098:blood supply; D008252:Macaca fascicularis; D023421:Models, Animal; D018482:Muscle, Skeletal / Q000098:blood supply; D015424:Reperfusion; D015427:Reperfusion Injury / Q000517:prevention & control
chemical_list: D000961:Antilymphocyte Serum